Bevacizumab (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bevacizumab" in Dutch language version.

refsWebsite

Global rank Dutch rank

3web.archive.org

1^st place

1^st place

2^nd place

8^th place

7^th place

27^th place

68^th place

39^th place

1zorginstituutnederland.nl

low place

low place

2,374^th place

1,153^rd place

1biotechstrategyblog.com

low place

low place

biotechstrategyblog.com

(en) Result from NEJM Lucentis v Avastin AMD CATT clinical trial, Biotech Strategy Blog

doi.org

The CATT Research Group (2011). Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration. N Engl J Med. 364: 1897-1908. DOI: 10.1056/NEJMoa1102673.
Lorenzo Moja, e.a. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2014 (9): CD011230. DOI: 10.1002/14651858.CD011230.pub2. Gearchiveerd van origineel op 19 september 2014. Geraadpleegd op 19 september 2014.

europa.eu

ema.europa.eu

Europese registratietekst

nejm.org

The CATT Research Group (2011). Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration. N Engl J Med. 364: 1897-1908. DOI: 10.1056/NEJMoa1102673.

nytimes.com

(en) F.D.A. Approves Drug’s Use for Breast Cancer - New York Times (22 Feb. 2008)

web.archive.org

(en) Pharmacotherapeutic report (t=4) on ranibizumab (Lucentis®) for the treatment of neovascular (wet) age-related macular degeneration. (AMD), Zorginstituut Nederland (23 januari 2012)
Lorenzo Moja, e.a. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2014 (9): CD011230. DOI: 10.1002/14651858.CD011230.pub2. Gearchiveerd van origineel op 19 september 2014. Geraadpleegd op 19 september 2014.
(nl) Risico op necrotiserende fasciitis bij gebruik van Avastin, College ter Beoordeling van Geneesmiddelen (27 mei 2013)

zorginstituutnederland.nl

(nl) Advies ranibizumab (Lucentis) bij de indicatie ‘neovasculaire leeftijdsgebonden maculadegeneratie’, Zorginstituut Nederland (13 augustus 2012)